KATHRYN PLEUNE: Open Payments
NPI 1467426122 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 30 payments from 12 companies in 2025. Trend: 2023 $991 · 2024 $904 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $388 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Ascendis Pharma Endocrinology Inc | 2 | $42 |
| Lilly USA, LLC | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Corcept Therapeutics | 1 | $23 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: Ozempic, BREZTRI, Wegovy, Yorvipath, CRENESSITY, GVOKE HYPOPEN, Korlym, ISTURISA.
Industry payments across MI — which companies pay providers there.
